Zonisamide- 15 N,d 4

Overview

Zonisamide - 15 N,d 4 is the 15 N- and deuterium labeled Zonisamide ( HY-B0124 ). Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor , with K i s of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Carbonic Anhydrase

Product Information

• Catalog No.: HY-B0124S3
• CAS No.: 2308764-57-8
• Molecular Formula: C8H4D4N15NO3S
• Molecular Weight: 217.24
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source